Zeitschriftenartikel
Heesen, C.,
Kleiter, I.,
Nguyen, F.,
Schäffler, N.,
Kasper, J.,
Köpke, S., &
Gaissmaier, W. (2010). Risk perception in natalizumab-treated multiple sclerosis patients and their neurologists.
Multiple Sclerosis,
16(12), 1507–1512. https://doi.org/10.1177/1352458510379819